H.R. 3795, to enact the Over-the-Counter Derivatives Markets Act of 2009, provisions related to changing the regulation on over-the-counter derivatives and how they are used by corporations
H.R.4173, to provide for financial regulatory reform, to protect consumers and investors, to enhance Federal understanding of insurance issues, to regulate over-the-counter derivatives markets, and for other purposes with provisions specifically changing the regulation on over-the-counter derivatives and how they are used by corporations
Senate draft legislation by Senator Dodd on financial reform with provisions on the regulation of over-the-counter derivatives Medical device tax as included as a means to pay for health care reform in H.R. 3962, the Affordable Health Care for America Act and the Senate Manager's Amendment (SA3298) on health care reform
H.Con Res 85 and S.Con Res 13, the FY2010 budget resolution and provisions related to the taxation of foreign earnings of U.S. multinational corporations H.R. 4213, the Tax Extenders Act of 2009, specifically including a provision to extend the research and development tax credit
S.1203, the GROWTH Act, a bill to extend the research credit through 2010 and to increase and make permanent the alternative
simplified research credit H.R. 3590, the Patient Protection and Affordable Care Act, the legislative vehicle used to pass Leader Reid's manager's amendment regarding health care reform on the Senate floor  
H.R. 3962, Affordable Health Care for America Act,to provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes Other Senate and House Committee Health Reform bills with an emphasis on physician disclosure, comparative effectiveness research, pain research, Medicare secondary payer, bundling, gainsharing, medical device registry, and medical device tax.
Medicare Secondary Payer provision, which was included in Ways and Means Chairman's Mark for HR 3200, the America's Affordable Health Choices Act, that would have increased exposure to liability for suppliers
S.540, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices
H.R.1346, Medical Device Safety Act, a bill that would remove federal preemption protection for certain medical devices
Reform of the 510 (k) regulatory pathway
H.R. 759, Food and Drug Administration Globalization Act, a bill to improve the safety of food, drugs, devices, and cosmetics
S. 882, the Drug and Device Accountability Act, a bill to ensure the safety and quality of medical products and enhance the
authorities of the FDA
H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness
research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund
S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness
research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund
H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative
effectiveness research for drugs, devices, and other therapies
S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and
device labeling and advertising
H.R. 3090, Health Equity &Accountability Act of 2009, provides for the elimination of racial and ethnic health disparities
S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies
H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies
S.1390, the Defense Authorization Bill, provisions related to pain management which would require a comprehensive pain care policy on pain management by the military health care system S.660, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies
H.R. 756, National Pain Care Policy Act, a bill to promote greater access to chronic pain therapies
S.1380, Medicare Payment Advisory Commission (MedPAC) Reform Act, a bill to make the commission an executive branch agency, and provide the Commission new resources and authority to implement Medicare payment policy S.301, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and the
manufacturers of drugs and devices
H.R. 3138, Physician Payments Sunshine Act, a bill that would require disclosure of the relationships between physicians and
the manufacturers of drugs and devices
H.R. 2502, Comparative Effectiveness Research Act of 2009, a bill to provide for the conduct of comparative effectiveness
research for drugs, devices, and other therapies and create a Comparative Effectiveness Research Trust Fund
S.1213, Patient-Centered Outcomes Research Act of 2009, a bill to provide for the conduct of comparative effectiveness
research for drugs, devices, and other therapies and to establish a Patient-Centered Outcomes Research Trust Fund
H.R. 2824, Doctor-Patient Relationship and Research Protection Act, a bill to support federally funded comparative
effectiveness research for drugs, devices, and other therapies
S.1142, Informed Health Care Decision Making Act, a bill with respect to the inclusion of effectiveness information in drug and
device labeling and advertising HR 2749, Food Safety Enhancement Act of 2009, grants FDA the authority and resources to oversee the safety of the nation's food supply.  Includes provisions related to registration fees, device import safety fees, and unique identifier provisions. S.560, the Employee Free Choice Act, a bill to establish an efficient system to enable employees to form, join, or assist labor
organizations and to provide for mandatory injunctions for unfair labor practices during the organizing efforts
H.R. 1409, the Employee Free Choice Act, a bill to establish an efficient system to enable employees to form, join, assist labor
organizations, and to provide for mandatory injunctions for unfair labor practices during the organizing efforts H.R. 4016, the Hazardous Materials Transportation Safety Act of 2009, specifically regarding the transportation of lithium batteries S.515. Patent Reform Act of 2009, provisions related specifically to innovative technologies
H.R. 1260, Patent Reform Act of 2009, provisions related specifically to innovative technologies
FIN - Financial Institutions/Investments/Securities TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid FOO - Food Industry (safety, labeling, etc.) LBR - Labor Issues/Antitrust/Workplace TRA - Transportation CPT - Copyright/Patent/Trademark
136 - Centers For Medicare and Medicaid Services (CMS) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 8 - Congressional Budget Office (CBO) 135 - Food & Drug Administration (FDA) 5 - Government Accountability Office (GAO) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 18 - Office of Management & Budget (OMB) 1 - SENATE
BOSTON SCIENTIFIC CORPORATION
1455 PENNSYLVANIA AVENUE, NW, SUITE 925, WASHINGTON, DC, 20004, US
STEVEN NEIL LAPIERRE MICHAEL MATTOON BRENDA BECKER STEVEN NEIL LAPIERRE MICHAEL MATTOON SCOTT REID BRENDA BECKER JEAN CECIL FRICK STEVEN NEIL LAPIERRE SCOTT REID MICHAEL MATTOON BRENDA BECKER JEAN CECIL FRICK STEVEN NEIL LAPIERRE MICHAEL MATTOON SCOTT REID BRENDA BECKER STEVEN NEIL LAPIERRE MICHAEL MATTOON BRENDA BECKER STEVEN NEIL LAPIERRE MICHAEL MATTOON BRENDA BECKER JEAN CECIL FRICK STEVEN NEIL LAPIERRE BRENDA BECKER JEAN CECIL FRICK MICHAEL MATTOON STEVEN NEIL LAPIERRE MICHAEL MATTOON BRENDA BECKER